2. Search Result
Search Result
Results for "

S.

" in MedChemExpress (MCE) Product Catalog:

9510

Inhibitors & Agonists

34

Screening Libraries

77

Fluorescent Dye

231

Biochemical Assay Reagents

555

Peptides

6

MCE Kits

118

Inhibitory Antibodies

1071

Natural
Products

611

Recombinant Proteins

715

Isotope-Labeled Compounds

305

Antibodies

121

Click Chemistry

164

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-E70234
    Sortase A, S. aureus

    SrtA

    		 Bacterial Others
    Sortase A, S. aureus (SrtA), a transpeptidase enzyme is present in many Gram-positive bacteria and helps in the recruitment of the cell surface proteins. Sortase A, S. aureus plays an important part in ligation of various molecules on the cell surfaces .
    Sortase A, S. aureus
  • HY-14926
    Levonadifloxacin

    (S)-(-)-Nadifloxacin; WCK 771

    		 Antibiotic Bacterial Infection
    Levonadifloxacin ((S)-(-)-Nadifloxacin; WCK 771) is a broad-spectrum anti-staphylococcal agent. Levonadifloxacin shows antibacterial activity against Methicillin (HY-121544)-susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA) strains, with a reduction of which phagocytized in THP-1 monocytes .
    Levonadifloxacin
  • HY-44688
    S.pombe lumazine synthase-IN-1

    		Bacterial Fungal Infection
    S.pombe lumazine synthase-IN-1 is an inhibitor of lumazine synthases with Ki values of 243 μM and 9.6 μM for Schizosaccharomyces pombe and Mycobacterium tuberculosis lumazine synthases, respectively .
    S.pombe lumazine synthase-IN-1
  • HY-125845A
    (S,S,S)-AHPC hydrochloride
    2 Publications Verification

    (S,S,S)-VH032-NH2 hydrochloride

    		 Ligands for E3 Ligase Cancer
    (S,S,S)-AHPC hydrochloride is a von Hippel-Lindau (VHL) amino building block. (S,S,S)-AHPC (Compound 27) is a ligand used as a negative control for (S,R,S)-AHPC. (S,R,S)-AHPC is the VH032-based VHL ligand used in the recruitment of the VHL protein .
    (S,S,S)-AHPC hydrochloride
  • HY-17518A
    (S,S)-Valifenalate

    (S,S)-IR5885; (S,S)-Valiphenal

    		 Fungal Infection
    (S,S)-Valifenalate ((S,S)-IR5885) is an acylamino acid fungicide and is used to control a wide range of fungi belonging to the class of Oomycetes. (S,S)-Valifenalate ((S,S)-IR5885) interferes with the cell-wall synthesis thus affecting the growth stages of the pathogens controlled, both outside (on the spores) or inside the plant (on the mycelium) .
    (S,S)-Valifenalate
  • HY-123109A
    (S,S,S)-AHPC-Boc

    (S,S,S)-VH032-Boc

    		 Ligands for E3 Ligase Cancer
    (S,S,S)-AHPC-Boc is the isomer of (S,R,S)-AHPC-Boc (HY-123109), and can be used as an experimental control. (S,R,S)-AHPC-Boc (VH032-Boc) is a ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC-Boc is used in PROTAC technology .
    (S,S,S)-AHPC-Boc
  • HY-152097
    (S)-ZG197

    		ClpP Bacterial Infection
    (S)-ZG197 is a highly selective Staphylococcus aureus Caseinolytic protease P (SaClpP) activator with an EC50 of 1.4 μM .
    (S)-ZG197
  • HY-14926R
    Levonadifloxacin (Standard)

    (S)-(-)-Nadifloxacin (Standard); WCK 771 (Standard)

    		 Antibiotic Bacterial Infection
    Levonadifloxacin (Standard) is the analytical standard of Levonadifloxacin. This product is intended for research and analytical applications. Levonadifloxacin ((S)-(-)-Nadifloxacin; WCK 771) is a broad-spectrum anti-staphylococcal agent. Levonadifloxacin shows antibacterial activity against Methicillin (HY-121544)-susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA) strains, with a reduction of which phagocytized in THP-1 monocytes[1].
    Levonadifloxacin (Standard)
  • HY-119813
    (S,S)-Sinogliatin

    (S,S)-HMS-5552; (S,S)-RO-5305552

    		 Glucokinase Metabolic Disease
    (S,S)-Sinogliatin ((S,S)-HMS-5552) is the (S,S) -enantiomer of Sinogliatin. Sinogliatin is a glucokinase activator that can be used to study type 2 diabetes .
    (S,S)-Sinogliatin
  • HY-14926A
    Levonadifloxacin (arginine) hydrate

    (S)-(-)-Nadifloxacin (arginine) hydrate; WCK-771A (arginine) hydrate

    		 Antibiotic Bacterial Infection
    Levonadifloxacin (arginine) hydrate is a broad-spectrum anti-staphylococcal agent. Levonadifloxacin (arginine) hydrate shows antibacterial activity against Methicillin (HY-121544)-susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA) strains, with a reduction of which phagocytized in THP-1 monocytes .
    Levonadifloxacin (arginine) hydrate
  • HY-107409B
    (S,S)-GNE 5729

    		Drug Isomer Others
    (S,S)-GNE 5729 is a (S,S)-enantiomer of GNE 5729 (HY-107409) .
    (S,S)-GNE 5729
  • HY-128888A
    (S,S)-GSK321

    		Isocitrate Dehydrogenase (IDH) Cancer
    (S,S)-GSK321 is a (S,S)-enantiomer of GSK321 .
    (S,S)-GSK321
  • HY-B0010C
    (S,S)-Formoterol

    (+)-Formoterol

    		 Interleukin Related Inflammation/Immunology
    (S,S)-Formoterol ((+)-Formoterol) is a (S,S)-enantiomer of Formoterol. (S,S)-Formoterol can promote asthma by enhancing IL-4 production in mast cells of the asthmatic airway .
    (S,S)-Formoterol
  • HY-167739
    (S,S)-Dehydroemetine

    		Endogenous Metabolite Neurological Disease
    (S,S)-Dehydroemetine is an antispasmodic compound with inhibitory activity on smooth muscle. (S,S)-Dehydroemetine can be used to inhibit diseases related to smooth muscle contraction .
    (S,S)-Dehydroemetine
  • HY-112403
    (S)-Roscovitine

    (S)-Seliciclib; (S)-CYC202

    		 CDK Neurological Disease
    (S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent and cross the blood-brain barrier CDKs inhibitor. (S)-Roscovitine shows neuroprotective efficacy. (S)-Roscovitine has the potential for the research of stroke .
    (S)-Roscovitine
  • HY-50856A
    Ruxolitinib (S enantiomer)
    4 Publications Verification

    S-Ruxolitinib; S-INCB18424

    		 JAK Cancer
    Ruxolitinib (S enantiomer) (S-Ruxolitinib) is the S-enantiomer of Ruxolitinib (HY-50856). Ruxolitinib (S enantiomer) is an orally active, potent JAK inhibitor .
    Ruxolitinib (S enantiomer)
  • HY-137428
    (S,S)-EDDS

    		Biochemical Assay Reagents Others
    (S,S)-EDDS is a stereoisomer of EDTA (HY-Y0682), and exhibits ability to chelate metal ions. (S,S)-EDDS exhibits good biodegradability in the environment, and can be used in environmental management and biotechnology .
    (S,S)-EDDS
  • HY-W074930
    (S)-Tenofovir

    (S)-GS 1278; (S)-PMPA; (S)-TDF

    		 HIV HBV Infection
    (S)-Tenofovir ((S)-GS 1278) is the less active S-enantiomer of Tenofovir. Tenofovir is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV) .
    (S)-Tenofovir
  • HY-14658A
    (S)-Thalidomide

    (S)-(-)-Thalidomide

    		 Molecular Glues Ligands for E3 Ligase Autophagy Apoptosis Metabolic Disease Inflammation/Immunology
    (S)-Thalidomide ((S)-(-)-Thalidomide) is the S-enantiomer of Thalidomide. (S)-Thalidomide has immunomodulatory, anti-inflammatory, antiangiogenic and pro-apoptotic effects . (S)-Thalidomide induces teratogenic effects by binding to cereblon (CRBN) .
    (S)-Thalidomide
  • HY-107661A
    S-(+)-Arundic Acid

    (S)ONO-2506; (S)-2-Propyloctanoic acid

    		 Drug Isomer Others
    S-(+)-Arundic Acid ((S)ONO-2506) is the S-enantiomer of Arundic Acid. Arundic acid is an astrocyte-modulating agent, has the potential for stroke and Alzheimer’s disease research .
    S-(+)-Arundic Acid
  • HY-14855A
    (S)-Tedizolid
    2 Publications Verification

    (S)-TR 700; (S)-DA 7157

    		 Bacterial Antibiotic Infection
    (S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.
    (S)-Tedizolid
  • HY-141848A
    (S,S)-BMS-984923

    		mGluR Neurological Disease
    (S,S)-BMS-984923 is a less active (S,S)-enantiomer of BMS-984923. (S,S)-BMS-984923 shows an EC50 >1μM for mGluR5 receptor . BMS-984923 is a potent mGluR5 silent allosteric modulator . (S,S)-BMS-984923 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    (S,S)-BMS-984923
  • HY-160144S1
    (S)-Lomedeucitinib

    (S)-BMS-986322

    		 JAK Inflammation/Immunology
    (S)-Lomedeucitinib ((S)-BMS-986322) is a S-enantiomer of Lomedeucitinib (HY-160144S). Lomedeucitinib is a tyrosine protein kinase (TYK2) inhibitor .
    (S)-Lomedeucitinib
  • HY-117488
    (S)-Grepafloxacin

    (S)-OPC-17116; (S)-dl-Grepafloxacin

    		 Bacterial Infection
    (S)-Grepafloxacin ((S)-OPC-17116) is the S-enantiomer of Grepafloxacin (HY-A0147) .
    (S)-Grepafloxacin
  • HY-14855AR
    (S)-Tedizolid (Standard)

    (S)-TR 700 (Standard); (S)-DA 7157 (Standard)

    		 Bacterial Antibiotic Infection
    (S)-Tedizolid (Standard) is the analytical standard of (S)-Tedizolid. This product is intended for research and analytical applications. (S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.
    (S)-Tedizolid (Standard)
  • HY-145572B
    (S)-Imlunestrant tosylate

    (S)-LY-3484356 tosylate

    		 Drug Isomer Cancer
    (S)-Imlunestrant ((S)-LY-3484356) tosylate is an (S)-enantiomer of Imlunestrant (HY-145572). (S)-Imlunestrant tosylate can be used in research of cancer .
    (S)-Imlunestrant tosylate
  • HY-B0432B
    (S)-Propafenone
    1 Publications Verification

    (S)-SA-79

    		 Sodium Channel Cardiovascular Disease
    (S)-Propafenone ((S)-SA-79) is the S-enantiomer of Propafenone. (S)-Propafenone ((S)-SA-79) exerts beta-blocking action and the sodium channel-dependent antiarrhythmic class 1 activity .
    (S)-Propafenone
  • HY-109854
    (S)-Lisofylline

    (S)-Lisophylline

    		 Drug Isomer Inflammation/Immunology
    (S)-Lisofylline ((S)-Lisophylline)) is a kind of lisofline (LSF) enantiomer with optical activity. (S)-Lisofylline can interconversion with pentoxifylline .
    (S)-Lisofylline
  • HY-N2037B
    (S)-Higenamine

    (S)-Norcoclaurine

    		 Endogenous Metabolite Others
    (S)-Higenamine ((S)-Norcoclaurine), a S-enantiomer of Higenamine, is the entry compound in benzylisoquinoline alkaloid biosynthesis. (S)-Higenamine is produced by the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) by norcoclaurine synthase (NCS) .
    (S)-Higenamine
  • HY-B0352A
    (S)-Mirtazapine

    (S)-Org3770; (S)-6-Azamianserin

    		 5-HT Receptor Neurological Disease
    (S)-Mirtazapine ((S)-Org3770) is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception. (S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2 .
    (S)-Mirtazapine
  • HY-78931B
    (S,S,S,S,R)-Boc-Dap-NE

    		Drug Intermediate Cancer
    (S,S,S,S,R)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (S,S,S,S,R)-Boc-Dap-NE
  • HY-100617
    (S)-4CPG

    (S)-4-Carboxyphenylglycine

    		 mGluR Neurological Disease
    (S)-4CPG ((S)-4-Carboxyphenylglycine) is a potent mGluR2 agonist. (S)-4CPG reduces hyperalgesia and allodynia associated with sciatic nerve contraction injury in rats. (S)-4CPG can be used in research on neurological diseases .
    (S)-4CPG
  • HY-136885
    (S,S)-TAPI-0

    		MMP Infection
    (S,S)-TAPI-0 is a matrix metalloproteinase (MMP) inhibitor that inhibits the growth of Chlamydia trachomatis by inhibiting PDF enzyme activity. (S,S)-TAPI-0 can be used to study Chlamydia infection .
    (S,S)-TAPI-0
  • HY-125743
    S-1 Methanandamide

    (S)-Methanandamide

    		 Cannabinoid Receptor Neurological Disease
    S-1 Methanandamide ((S)-Methanandamide), an Anandamide analog, is a CB1 receptor ligand with a Ki of 173 nM. S-1 Methanandamide inhibits electrically-evoked twitch response in mouse vas deferens with an IC50 value of 230 nM .
    S-1 Methanandamide
  • HY-142139S
    (S,S)-Iso Valganciclovir-d8 hydrochloride

    		Isotope-Labeled Compounds Others
    (S,S)-Iso Valganciclovir-d8 (hydrochloride) is the deuterium labeled (S,S)-Iso Valganciclovir hydrochloride .
    (S,S)-Iso Valganciclovir-d8 hydrochloride
  • HY-19323A
    (S)-Ceralasertib
    2 Publications Verification

    (S)-AZD6738

    		 ATM/ATR Cancer
    (S)-Ceralasertib ((S)-AZD6738) is the S-enantiomer of Ceralasertib (HY-19323). (S)-Ceralasertib is the inhibitor for ataxia telangiectasia mutated and rad3 related (ATR) .
    (S)-Ceralasertib
  • HY-105271
    S-312-d

    S-(+)-S-312-d

    		 Calcium Channel Others
    S-312-d (S-(+)-S-312-d) is a calcium channel blocker with the activity of protecting the kidney from ischemic acute renal failure. S-312-d (0.01-0.1mg/kg b.wt. iv) administered before ischemia has a dose-dependent protective effect on ischemia-induced renal damage, improves the survival rate of ischemic rats, and reduces renal cortical edema and the increase in renal tissue calcium content.
    S-312-d
  • HY-Y1069
    (S)-Malic acid
    1 Publications Verification

    (S)-Hydroxybutanedioic acid; (S)-E 296; L-Malic acid

    		 Endogenous Metabolite Metabolic Disease
    (S)-Malic acid ((S)-2-Hydroxysuccinic acid) is a dicarboxylic acid in naturally occurring form, contributes to the pleasantly sour taste of fruits and is used as a food additive.
    (S)-Malic acid
  • HY-15790H
    (S)-Elobixibat

    (S)-A 3309; (S)-AZD 7806

    		 Apical Sodium-Dependent Bile Acid Transporter TNF Receptor Interleukin Related Metabolic Disease Inflammation/Immunology
    (S)-Elobixibat is the S enantiomer of Elobixibat (HY-15790). (S)-Elobixibat is an orally effective Apical Sodium-Dependent Bile (IBAT) inhibitor. (S)-Elobixibat decreases LDL cholesterol, increases serum GLP-1, promotes colon motility, and has the potential to treat metabolic syndrome. (S)-Elobixibat can be used to study constipation, dyslipidemia, non-alcoholic hepatitis, and liver tumors .
    (S)-Elobixibat
  • HY-106841A
    (S)-Draflazine

    (-)-Draflazine; (S)-R-75231; (S)-R88021

    		 Adenosine Receptor Drug Isomer Others
    (S)-Draflazine ((-)-Draflazine) is the (S)-configuration of Draflazine (HY-106841). (S)-Draflazine is a potent blocker of nucleoside transport .
    (S)-Draflazine
  • HY-15114
    S 17092

    S 17092-1

    		 Prolyl Endopeptidase (PREP) Apoptosis Neurological Disease
    S 17092 (S 17092-1) is an orally active cerebral prolyl-endopeptidase (PEP) inhibitor with an IC50 of 1.2 nM. S 17092 inhibits cell apoptosis. S 17092 mechanism of action is to inhibit the activity of PEP, slowing down the degradation of neuroactive peptides and thus enhancing memory function. S 17092 can be used for the research of memory impairment and cognitive disorders associated with cerebral aging .
    S 17092
  • HY-15344A
    (S,S)-Ketone monoester

    		Drug Isomer Neurological Disease
    (S,S)-Ketone monoester is a (S,S)-enantiomer of Ketone monoester (HY-15344). Ketone monoester elevates the AcAc and acetone levels, thereby produces sustained ketosis and significantly delays central nervous system oxygen toxicity (CNS-OT) seizures .
    (S,S)-Ketone monoester
  • HY-100741A
    (S,R)-S63845

    		Bcl-2 Family Cancer
    (S,R)-S63845 is the isomer of S63845 (HY-100741), and can be used as an experimental control. S63845 is a potent and selective myeloid cell leukemia 1 (MCL1) inhibitor with a Kd of 0.19 nM for human MCL1 .
    (S,R)-S63845
  • HY-Y1126
    (2S)-2-Pyrrolidinemethanol

    (S)-(+)-Prolinol; (S)-(+)-Pyrrolidin-2-ylmethanol; (S)-1-(Pyrrolidin-2-yl)methanol

    		 Biochemical Assay Reagents Others
    (2S)-2-Pyrrolidinemethanol ((S)-(+)-Prolinol; (S)-(+)-Pyrrolidin-2-ylmethanol; (S)-1-(Pyrrolidin-2-yl)methanol) reveals binucleophilic character and can be anchored to phthalonitrile derivative from both nitrogen and oxygen atoms. (2S)-2-Pyrrolidinemethanol can be utilized as chiral catalyst .
    (2S)-2-Pyrrolidinemethanol
  • HY-N3045
    (S,S)-Pisatin

    		Others Others
    (S,S)-Pisatin (compound 8) is a dimeric pterocarpan derivative is isolated from the grains of millettia pachyloba .
    (S,S)-Pisatin
  • HY-10502A
    Tipifarnib (S enantiomer)

    IND-58359 S enantiomer; (S)-(-)-R-115777

    		 Farnesyl Transferase Cancer
    Tipifarnib S enantiomer is the S-enantiomer of Tipifarnib. Tipifarnib is a potent and specific farnesyltransferase (FTase) inhibitor with IC50 of 0.6 nM. Tipifarnib S enantiomer is the less active isomer.
    Tipifarnib (S enantiomer)
  • HY-W718425
    (S)-13-Hydroxyoctadecanoic acid

    (13S)-13-Hydroxyoctadecanoic acid

    		 Biochemical Assay Reagents Metabolic Disease
    (S)-13-Hydroxyoctadecanoic acid ((13S)-13-Hydroxyoctadecanoic acid) is an ester product.
    (S)-13-Hydroxyoctadecanoic acid
  • HY-106577A
    (-)-(S)-Cibenzoline

    Escibenzoline; (-)-(S)-Cifenline; (-)-(S)-Ro 22-7796

    		 Potassium Channel Metabolic Disease
    (-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent .
    (-)-(S)-Cibenzoline
  • HY-B0006B
    (S)-Carvedilol

    (S)-BM 14190

    		 Adrenergic Receptor Cardiovascular Disease
    (S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX) .
    (S)-Carvedilol
  • HY-W141774
    S-(2-Carboxyethyl)-L-cysteine

    S-Carboxyethylcysteine

    		 Amino Acid Derivatives Metabolic Disease
    S-(2-Carboxyethyl)-L-cysteine (S-Carboxyethylcysteine) is a non-protein (modified) sulfur amino acid. S-(2-Carboxyethyl)-L-cysteine is present in Acacia seed. S-(2-Carboxyethyl)-L-cysteine can affect the seed’s protein use in rats. S-(2-Carboxyethyl)-L-cysteine suppresses the methionine-induced growth rate, and has a negative effect on the plasma amino acid levels in rats .
    S-(2-Carboxyethyl)-L-cysteine

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: